Literature DB >> 15208302

Molecular interactions that confer latency to transforming growth factor-beta.

Geoffrey D Young1, Joanne E Murphy-Ullrich.   

Abstract

A major point of regulation of transforming growth factor-beta (TGF-beta) function is through control of activation of the latent TGF-beta complex, which consists of the latency associated peptide (LAP) secreted in non-covalent association with mature TGF-beta. Activation involves proteolysis, dissociation, or altered binding of LAP. However, the mechanism by which LAP confers latency to TGF-beta is poorly understood. Previously, we identified a conserved sequence near the N terminus of LAP as a site of thrombospondin-1 (TSP1) binding to the latent complex. Now we show that expression of the TGF-beta1-latent complex deleted in the TSP1 binding site ((54)LSKL) of LAP (DeltaLSKL LAP) results in secretion of LAP, but not of mature TGF-beta. DeltaLSKL LAP also fails to bind soluble or immobilized TGF-beta1. Consistent with an inability to bind the mature domain, DeltaLSKL LAP is unable to confer latency to TGF-beta, suggesting that the LSKL sequence is important, not only for TSP1 binding and activation, but also for binding to the mature domain. We identified the sequence (94)RKPK in the receptor-binding region of mature TGF-beta1 as the binding site for LAP. Peptides of the RKPK sequence bind LAP and inhibit LAP/TGF-beta association. RKPK peptides also activate latent TGF-beta, presumably by disrupting LAP-mature TGF-beta interactions. These studies provide a molecular basis for both latency and activation by TSP1 through the LSKL sequence of LAP binding to the RKPK sequence of mature TGF-beta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208302     DOI: 10.1074/jbc.M405658200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.

Authors:  Nathalie di Clemente; Soazik P Jamin; Alexey Lugovskoy; Paul Carmillo; Christian Ehrenfels; Jean-Yves Picard; Adrian Whitty; Nathalie Josso; R Blake Pepinsky; Richard L Cate
Journal:  Mol Endocrinol       Date:  2010-09-22

Review 2.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

3.  Induction of chondrogenesis of adipose-derived stem cells by novel recombinant TGF-β3 fusion protein.

Authors:  Dong Zheng; Yang Dan; Peng Huang; Tian Xia; Shu-Hua Yang; Wei-Hua Xu; Cao Yang; Guo-Hui Liu; Xian-Zhe Liu; Yong Feng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

Review 4.  Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders.

Authors:  Stephen L Nishimura
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

Review 5.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

6.  Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis.

Authors:  Alessandro Prete; Agnes S Lo; Peter M Sadow; Swati S Bhasin; Zeus A Antonello; Danica M Vodopivec; Soumya Ullas; Jennifer N Sims; John Clohessy; Ann M Dvorak; Tracey Sciuto; Manoj Bhasin; Joanne E Murphy-Ullrich; Jack Lawler; S Ananth Karumanchi; Carmelo Nucera
Journal:  Clin Cancer Res       Date:  2018-08-03       Impact factor: 12.531

7.  Myeloid-specific deletion of thrombospondin 1 protects against inflammation and insulin resistance in long-term diet-induced obese male mice.

Authors:  Hasiyet Memetimin; Dong Li; Kaiyuan Tan; Changcheng Zhou; Ying Liang; Yadi Wu; Shuxia Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-10-23       Impact factor: 4.310

8.  Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin.

Authors:  Yong Zhou; Katri Koli; James S Hagood; Mi Miao; Mahendra Mavalli; Daniel B Rifkin; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

9.  Expression of nodal signalling components in cycling human endometrium and in endometrial cancer.

Authors:  Irene Papageorgiou; Peter K Nicholls; Fang Wang; Martin Lackmann; Yogeshwar Makanji; Lois A Salamonsen; David M Robertson; Craig A Harrison
Journal:  Reprod Biol Endocrinol       Date:  2009-10-29       Impact factor: 5.211

10.  The interaction of Thrombospondins with extracellular matrix proteins.

Authors:  Kemin Tan; Jack Lawler
Journal:  J Cell Commun Signal       Date:  2009-10-16       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.